BIOTRONIK Announces First Enrollments in the BIO|GUARD-MI Study
BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced today the first enrollments in the BIO…
BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced today the first enrollments in the BIO…
BIOTRONIK, ein führender Hersteller kardiovaskulärer Medizintechnik, hat heute die Aufnahme der ersten Patienten in die…
BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced today that the first patient has been…
Experts in cardiology and electrophysiology met at this year's 8th annual EMB (Expert Meeting Berlin) Conference[1] to d…
MADIT-II Showed that 75% of Patients Did Not Receive Shock Therapy -- Did They Really Require an ICD Implant? 2012 -…
MADIT-II-Studie hat gezeigt, dass 75% der ICD-Patienten keine Schocktherapie erhielten - war die Implantation angemessen…
Anlässlich des TCT präsentierte Prof. Kornowski während der Session "Innovative Developments & Future Concepts: Novel BM…